デフォルト表紙
市場調査レポート
商品コード
1522243

大規模および小規模バイオプロセスの世界市場レポート 2024年

Large And Small-Scale Bioprocessing Global Market Report 2024

出版日: | 発行: The Business Research Company | ページ情報: 英文 175 Pages | 納期: 2~10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.78円
大規模および小規模バイオプロセスの世界市場レポート 2024年
出版日: 2024年07月29日
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2~10営業日
ご注意事項 :
本レポートの納品は、最新情報反映のため受注時に適宜更新しお届けいたします。
更新情報の反映作業にあたり納期もレポート毎に異なりますので、ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

大規模および小規模バイオプロセス市場規模は、今後数年で急成長が見込まれます。2028年の年間平均成長率(CAGR)は13.5%で、990億3,000万米ドルに成長します。予測期間中に予想される成長は、ヘルスケア支出の増加、製薬およびバイオテクノロジー産業の拡大、技術の進歩、規制圧力、食品安全に対する意識の高まり、COVID-19パンデミックの影響など、いくつかの要因に影響されます。この期間に予想される主な動向には、先端技術の採用、地理的拡大、滅菌サービスのアウトソーシング、持続可能な実践の促進、ハイブリッド滅菌技術の開発、カスタマイズされた滅菌ソリューションの提供などが含まれます。

生物製剤に対する需要の増加は、今後の大規模および小規模バイオプロセス市場の拡大を牽引するものと思われます。生物製剤には、ワクチン、血液および血液成分、遺伝子治療薬、組織、組換え治療用タンパク質など、生物またはその成分に由来する医薬品が含まれます。生物製剤の需要が高まっている背景には、バイオテクノロジーの進歩、疾病メカニズムの理解向上、標的療法や個別化療法の要望があります。生物製剤の開発と商業化を成功させるには、大規模バイオプロセスと小規模バイオプロセスの両方が重要な役割を果たします。小規模バイオプロセスは、初期段階の開発、最適化、フィージビリティ・スタディに極めて重要であり、一方、大規模バイオプロセスは、商業的流通に向けた生物製剤の効率的で一貫性のある、規制に準拠した生産を保証します。例えば、米国の医学図書館である国立医学図書館(National Library of Medicine)によると、2024年2月、食品医薬品局(FDA)は2023年に29の新規化学物質(NCE)と25の新規生物学的製剤(NBE)を含む55の新薬を承認し、2022年の37の承認に比べ50%増加しました。したがって、生物製剤に対する需要の高まりが大規模および小規模バイオプロセス市場成長の原動力となっています。

大規模および小規模バイオプロセス市場の主要企業は、顧客に強化された機能を提供するため、シングルユース遠心分離機システムの導入など、製品提供の革新を進めています。シングルユース遠心分離機システムは、バイオプロセスにおける生物学的物質の分離用に設計された使い捨ての滅菌済み装置です。例えば、米国のバイオテクノロジー企業であるサーモフィッシャーサイエンティフィック社は、2022年9月にDynaSpin単回使用遠心分離システムを発表しました。このシステムは、分離プロセスを簡素化し、深層ろ過カートリッジの必要性を減らし、生物製剤生産における製品収率の向上、作業効率、コスト削減、持続可能な実践などの利点を提供することにより、大規模細胞培養採取を強化することを目的としています。ダイナスピンシステムは、従来のハーベストシステムと比較して、材料の使用量と廃棄物を大幅に削減することにより、生産におけるコスト削減に貢献し、持続可能な目標をサポートします。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界の市場規模と成長

  • 世界の大規模および小規模バイオプロセス市場:促進要因と抑制要因
    • 市場促進要因
    • 市場抑制要因
  • 世界の大規模および小規模バイオプロセス市場の実績:規模と成長、2018年~2023年
  • 世界の大規模および小規模バイオプロセス市場の予測:規模と成長、2023年~2028年、2033年

第6章 市場セグメンテーション

  • 世界の大規模および小規模バイオプロセス市場:製品別、実績と予測、2018年~2023年、2023年~2028年、2033年
  • バイオリアクターまたは発酵槽
  • 細胞培養製品
  • 濾過アセンブリ
  • バイオリアクターアクセサリ
  • バッグと容器
  • その他の製品
  • 世界の大規模および小規模バイオプロセス市場:モード別、実績と予測、2018年~2023年、2023年~2028年、2033年
  • 社内
  • アウトソーシング
  • 世界の大規模および小規模バイオプロセス市場:ワークフロー別、実績と予測、2018年~2023年、2023年~2028年、2033年
  • 下流処理
  • 発酵
  • 上流処理
  • 世界の大規模および小規模バイオプロセス市場:スケール別、実績と予測、2018年~2023年、2023年~2028年、2033年
  • 産業規模
  • 小規模
  • 世界の大規模および小規模バイオプロセス市場:用途別、実績と予測、2018年~2023年、2023年~2028年、2033年
  • バイオ医薬品
  • 特殊工業用化学品
  • 環境補助

第7章 地域別・国別分析

  • 世界の大規模および小規模バイオプロセス市場:地域別、実績と予測、2018年~2023年、2023年~2028年、2033年
  • 世界の大規模および小規模バイオプロセス市場:国別、実績と予測、2018年~2023年、2023年~2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • 大規模および小規模バイオプロセス市場:競合情勢
  • 大規模および小規模バイオプロセス市場:企業プロファイル
    • F. Hoffmann-La Roche AG
    • Merck & Co. Inc.
    • Bayer AG
    • Sanofi S.A.
    • Bristol Myers Squibb Company

第31章 その他の大手企業と革新的企業

  • Thermo Fisher Scientific Inc.
  • AstraZeneca PLC
  • Novartis AG
  • GlaxoSmithKline PLC
  • 3M Company
  • Takeda Pharmaceutical Company Ltd.
  • Danaher Corporation
  • Boehringer Ingelheim International GmbH
  • Novo Nordisk A/S
  • Becton Dickinson and Company(BD)
  • Teva Pharmaceutical Industries Ltd.
  • DAIICHI SANKYO COMPANY LIMITED
  • Lonza Group
  • Sun Pharmaceutical Industries Ltd.
  • GE Healthcare Life Sciences

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと潜在的な分析

第36章 付録

目次
Product Code: r18396

Large and small-scale bioprocessing are critical facets of the biotechnology and pharmaceutical sectors, employing living cells or their components to produce desired outputs such as pharmaceuticals, chemicals, and biofuels. Large-scale bioprocessing denotes the industrial-level manufacturing of biological products, utilizing large bioreactors and substantial infrastructure. Conversely, small-scale bioprocessing entails the production of biological products on a smaller scale, often for research, development, pilot studies, or specialized markets.

The primary products of both large and small-scale bioprocessing encompass bioreactors or fermenters, cell culture items, filtration assemblies, bioreactor accessories, bags, containers, and others. Bioreactors, also known as fermenters, are vessels engineered to facilitate the growth and metabolic processes of microorganisms or cells under controlled conditions to yield desired biological outputs. They are utilized through various modalities, including in-house and outsourced, and cater to several workflows, predominantly downstream processing, fermentation, and upstream processing. These products find application across a range of scales, from industrial to small-scale, and are employed in diverse sectors such as biopharmaceuticals, specialty industrial chemicals, and environmental aids.

The large and small-scale bioprocessing market research report is one of a series of new reports from The Business Research Company that provides large and small-scale bioprocessing market statistics, including large and small-scale bioprocessing industry global market size, regional shares, competitors with a large and small-scale bioprocessing market share, detailed large and small-scale bioprocessing market segments, market trends and opportunities, and any further data you may need to thrive in the large and small-scale bioprocessing industry. This large and small-scale bioprocessing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The large and small-scale bioprocessing market size has grown rapidly in recent years. It will grow from $52.59 billion in 2023 to $59.63 billion in 2024 at a compound annual growth rate (CAGR) of 13.4%. The growth in the historic period can be attributed to regulatory standards, medical industry growth, technological advancements, pharmaceutical and biotechnology investments, and food safety concerns.

The large and small-scale bioprocessing market size is expected to see rapid growth in the next few years. It will grow to $99.03 billion in 2028 at a compound annual growth rate (CAGR) of 13.5%. The anticipated growth during the forecast period is influenced by several factors, including the rise in healthcare spending, the expansion of the pharmaceutical and biotechnology industries, technological advancements, regulatory pressures, heightened awareness of food safety, and the repercussions of the COVID-19 pandemic. Key trends expected in this period encompass the adoption of advanced technologies, geographical expansion, the outsourcing of sterilization services, the promotion of sustainable practices, the development of hybrid sterilization techniques, and the provision of customized sterilization solutions.

The increasing demand for biologics is poised to drive the expansion of the large and small-scale bioprocessing market in the future. Biologics encompass medicinal products derived from living organisms or their components, including vaccines, blood and blood components, gene therapies, tissues, and recombinant therapeutic proteins. The escalating demand for biologics is attributed to advancements in biotechnology, enhanced understanding of disease mechanisms, and the desire for targeted and personalized therapies. Both large-scale and small-scale bioprocessing play vital roles in the successful development and commercialization of biologics. Small-scale bioprocessing is crucial for early-stage development, optimization, and feasibility studies, whereas large-scale bioprocessing ensures efficient, consistent, and regulatory-compliant production of biologics for commercial distribution. For instance, in February 2024, according to the National Library of Medicine, a US-based medical library, the Food and Drug Administration (FDA) approved 55 new drugs in 2023, including 29 new chemical entities (NCEs) and 25 new biological entities (NBEs), marking a 50% increase compared to the 37 approvals in 2022. Hence, the growing demand for biologics is a driving force behind the growth of the large and small-scale bioprocessing market.

Key players in the large and small-scale bioprocessing market are innovating their product offerings, such as introducing single-use centrifuge systems, to provide customers with enhanced features. Single-use centrifuge systems are disposable and pre-sterilized devices designed for the separation of biological materials in bioprocessing. For instance, in September 2022, Thermo Fisher Scientific Inc., a US-based biotechnology company, unveiled the DynaSpin Single-Use Centrifuge system. This system aims to enhance large-scale cell culture harvesting by simplifying the separation process, reducing the need for depth filtration cartridges, and delivering advantages such as improved product yield, operational efficiency, cost savings, and sustainable practices in biologics production. The DynaSpin system contributes to cost reduction in production and supports sustainability objectives by significantly reducing material usage and waste compared to traditional harvest systems.

In December 2022, Merck KGaA, a German science and technology company, purchased Erbi Biosystems for an undisclosed sum. This acquisition bolsters Merck's portfolio in upstream therapeutic proteins, facilitating scalable cell-based perfusion bioreactor processes spanning from 2 milliliters (mL) to 2000 liters (L). Erbi Biosystems, based in the US, offers a range of bioprocessing solutions catering to both large and small-scale applications.

Major companies operating in the large and small-scale bioprocessing market are F. Hoffmann-La Roche AG, Merck & Co. Inc., Bayer AG, Sanofi S.A., Bristol Myers Squibb Company, Thermo Fisher Scientific Inc., AstraZeneca PLC, Novartis AG, GlaxoSmithKline PLC, 3M Company, Takeda Pharmaceutical Company Ltd., Danaher Corporation, Boehringer Ingelheim International GmbH, Novo Nordisk A/S, Becton Dickinson and Company (BD), Teva Pharmaceutical Industries Ltd., DAIICHI SANKYO COMPANY LIMITED, Lonza Group, Sun Pharmaceutical Industries Ltd., GE Healthcare Life Sciences, Sartorius AG, Dr. Reddy's Laboratories Ltd., Alkem Laboratories Limited, Piramal Enterprises Ltd

North America was the largest region in the large and small-scale bioprocessing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the large and small-scale bioprocessing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the large and small-scale bioprocessing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The large and small-scale bioprocessing market consists of revenues earned by entities by providing plant cell bioprocessing, microbial bioprocessing, animal cell bioprocessing, and algal bioprocessing. The market value includes the value of related goods sold by the service provider or included within the service offering. The large and small-scale bioprocessing market also includes sales of shakers, incubators, and cell culture media. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Large And Small-Scale Bioprocessing Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on large and small-scale bioprocessing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for large and small-scale bioprocessing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The large and small-scale bioprocessing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product: Bioreactors Or Fermenters; Cell Culture Products; Filtration Assemblies; Bioreactors Accessories; Bags And Containers; Other Products
  • 2) By Mode: In-house; Outsourced
  • 3) By Workflow: Downstream Processing; Fermentation; Upstream Processing
  • 4) By Scale: Industrial Scale; Small Scale
  • 5) By Application: Biopharmaceuticals; Specialty Industrial Chemicals; Environmental Aids
  • Companies Mentioned: F. Hoffmann-La Roche AG; Merck & Co. Inc.; Bayer AG; Sanofi S.A.; Bristol Myers Squibb Company
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Large And Small-Scale Bioprocessing Market Characteristics

3. Large And Small-Scale Bioprocessing Market Trends And Strategies

4. Large And Small-Scale Bioprocessing Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Large And Small-Scale Bioprocessing Market Size and Growth

  • 5.1. Global Large And Small-Scale Bioprocessing Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Large And Small-Scale Bioprocessing Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Large And Small-Scale Bioprocessing Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Large And Small-Scale Bioprocessing Market Segmentation

  • 6.1. Global Large And Small-Scale Bioprocessing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Bioreactors Or Fermenters
  • Cell Culture Products
  • Filtration Assemblies
  • Bioreactors Accessories
  • Bags And Containers
  • Other Products
  • 6.2. Global Large And Small-Scale Bioprocessing Market, Segmentation By Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • In-house
  • Outsourced
  • 6.3. Global Large And Small-Scale Bioprocessing Market, Segmentation By Workflow, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Downstream Processing
  • Fermentation
  • Upstream Processing
  • 6.4. Global Large And Small-Scale Bioprocessing Market, Segmentation By Scale, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Industrial Scale
  • Small Scale
  • 6.5. Global Large And Small-Scale Bioprocessing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Biopharmaceuticals
  • Specialty Industrial Chemicals
  • Environmental Aids

7. Large And Small-Scale Bioprocessing Market Regional And Country Analysis

  • 7.1. Global Large And Small-Scale Bioprocessing Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Large And Small-Scale Bioprocessing Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Large And Small-Scale Bioprocessing Market

  • 8.1. Asia-Pacific Large And Small-Scale Bioprocessing Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Large And Small-Scale Bioprocessing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Large And Small-Scale Bioprocessing Market, Segmentation By Scale, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Large And Small-Scale Bioprocessing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Large And Small-Scale Bioprocessing Market

  • 9.1. China Large And Small-Scale Bioprocessing Market Overview
  • 9.2. China Large And Small-Scale Bioprocessing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Large And Small-Scale Bioprocessing Market, Segmentation By Scale, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Large And Small-Scale Bioprocessing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Large And Small-Scale Bioprocessing Market

  • 10.1. India Large And Small-Scale Bioprocessing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Large And Small-Scale Bioprocessing Market, Segmentation By Scale, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Large And Small-Scale Bioprocessing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Large And Small-Scale Bioprocessing Market

  • 11.1. Japan Large And Small-Scale Bioprocessing Market Overview
  • 11.2. Japan Large And Small-Scale Bioprocessing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Large And Small-Scale Bioprocessing Market, Segmentation By Scale, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Large And Small-Scale Bioprocessing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Large And Small-Scale Bioprocessing Market

  • 12.1. Australia Large And Small-Scale Bioprocessing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Large And Small-Scale Bioprocessing Market, Segmentation By Scale, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Large And Small-Scale Bioprocessing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Large And Small-Scale Bioprocessing Market

  • 13.1. Indonesia Large And Small-Scale Bioprocessing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Large And Small-Scale Bioprocessing Market, Segmentation By Scale, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Large And Small-Scale Bioprocessing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Large And Small-Scale Bioprocessing Market

  • 14.1. South Korea Large And Small-Scale Bioprocessing Market Overview
  • 14.2. South Korea Large And Small-Scale Bioprocessing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Large And Small-Scale Bioprocessing Market, Segmentation By Scale, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Large And Small-Scale Bioprocessing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Large And Small-Scale Bioprocessing Market

  • 15.1. Western Europe Large And Small-Scale Bioprocessing Market Overview
  • 15.2. Western Europe Large And Small-Scale Bioprocessing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Large And Small-Scale Bioprocessing Market, Segmentation By Scale, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Large And Small-Scale Bioprocessing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Large And Small-Scale Bioprocessing Market

  • 16.1. UK Large And Small-Scale Bioprocessing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Large And Small-Scale Bioprocessing Market, Segmentation By Scale, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Large And Small-Scale Bioprocessing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Large And Small-Scale Bioprocessing Market

  • 17.1. Germany Large And Small-Scale Bioprocessing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Large And Small-Scale Bioprocessing Market, Segmentation By Scale, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Large And Small-Scale Bioprocessing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Large And Small-Scale Bioprocessing Market

  • 18.1. France Large And Small-Scale Bioprocessing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Large And Small-Scale Bioprocessing Market, Segmentation By Scale, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Large And Small-Scale Bioprocessing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Large And Small-Scale Bioprocessing Market

  • 19.1. Italy Large And Small-Scale Bioprocessing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Large And Small-Scale Bioprocessing Market, Segmentation By Scale, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Large And Small-Scale Bioprocessing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Large And Small-Scale Bioprocessing Market

  • 20.1. Spain Large And Small-Scale Bioprocessing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Large And Small-Scale Bioprocessing Market, Segmentation By Scale, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Large And Small-Scale Bioprocessing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Large And Small-Scale Bioprocessing Market

  • 21.1. Eastern Europe Large And Small-Scale Bioprocessing Market Overview
  • 21.2. Eastern Europe Large And Small-Scale Bioprocessing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Large And Small-Scale Bioprocessing Market, Segmentation By Scale, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Large And Small-Scale Bioprocessing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Large And Small-Scale Bioprocessing Market

  • 22.1. Russia Large And Small-Scale Bioprocessing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Large And Small-Scale Bioprocessing Market, Segmentation By Scale, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Large And Small-Scale Bioprocessing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Large And Small-Scale Bioprocessing Market

  • 23.1. North America Large And Small-Scale Bioprocessing Market Overview
  • 23.2. North America Large And Small-Scale Bioprocessing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Large And Small-Scale Bioprocessing Market, Segmentation By Scale, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Large And Small-Scale Bioprocessing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Large And Small-Scale Bioprocessing Market

  • 24.1. USA Large And Small-Scale Bioprocessing Market Overview
  • 24.2. USA Large And Small-Scale Bioprocessing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Large And Small-Scale Bioprocessing Market, Segmentation By Scale, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Large And Small-Scale Bioprocessing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Large And Small-Scale Bioprocessing Market

  • 25.1. Canada Large And Small-Scale Bioprocessing Market Overview
  • 25.2. Canada Large And Small-Scale Bioprocessing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Large And Small-Scale Bioprocessing Market, Segmentation By Scale, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Large And Small-Scale Bioprocessing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Large And Small-Scale Bioprocessing Market

  • 26.1. South America Large And Small-Scale Bioprocessing Market Overview
  • 26.2. South America Large And Small-Scale Bioprocessing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Large And Small-Scale Bioprocessing Market, Segmentation By Scale, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Large And Small-Scale Bioprocessing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Large And Small-Scale Bioprocessing Market

  • 27.1. Brazil Large And Small-Scale Bioprocessing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Large And Small-Scale Bioprocessing Market, Segmentation By Scale, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Large And Small-Scale Bioprocessing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Large And Small-Scale Bioprocessing Market

  • 28.1. Middle East Large And Small-Scale Bioprocessing Market Overview
  • 28.2. Middle East Large And Small-Scale Bioprocessing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Large And Small-Scale Bioprocessing Market, Segmentation By Scale, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Large And Small-Scale Bioprocessing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Large And Small-Scale Bioprocessing Market

  • 29.1. Africa Large And Small-Scale Bioprocessing Market Overview
  • 29.2. Africa Large And Small-Scale Bioprocessing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Large And Small-Scale Bioprocessing Market, Segmentation By Scale, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Large And Small-Scale Bioprocessing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Large And Small-Scale Bioprocessing Market Competitive Landscape And Company Profiles

  • 30.1. Large And Small-Scale Bioprocessing Market Competitive Landscape
  • 30.2. Large And Small-Scale Bioprocessing Market Company Profiles
    • 30.2.1. F. Hoffmann-La Roche AG
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Merck & Co. Inc.
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Bayer AG
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Sanofi S.A.
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Bristol Myers Squibb Company
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Large And Small-Scale Bioprocessing Market Other Major And Innovative Companies

  • 31.1. Thermo Fisher Scientific Inc.
  • 31.2. AstraZeneca PLC
  • 31.3. Novartis AG
  • 31.4. GlaxoSmithKline PLC
  • 31.5. 3M Company
  • 31.6. Takeda Pharmaceutical Company Ltd.
  • 31.7. Danaher Corporation
  • 31.8. Boehringer Ingelheim International GmbH
  • 31.9. Novo Nordisk A/S
  • 31.10. Becton Dickinson and Company (BD)
  • 31.11. Teva Pharmaceutical Industries Ltd.
  • 31.12. DAIICHI SANKYO COMPANY LIMITED
  • 31.13. Lonza Group
  • 31.14. Sun Pharmaceutical Industries Ltd.
  • 31.15. GE Healthcare Life Sciences

32. Global Large And Small-Scale Bioprocessing Market Competitive Benchmarking

33. Global Large And Small-Scale Bioprocessing Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Large And Small-Scale Bioprocessing Market

35. Large And Small-Scale Bioprocessing Market Future Outlook and Potential Analysis

  • 35.1 Large And Small-Scale Bioprocessing Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Large And Small-Scale Bioprocessing Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Large And Small-Scale Bioprocessing Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer